The SARS-CoV-2 pandemic sweeps the globe, MSL researchers respond
Since the emergence of the COVID-19 pandemic, the work of MSL faculty has been instrumental in understanding and combatting the virus. Much of the progress made through variant sequencing, vaccine development and life–saving treatments have roots in research carried out within the within the MSL. Highlights of the significant contributions made to the global effort to curb the pandemic include:
March 2020
AbCellera and Eli Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
June 2020
Dr. Terry Snutch Leads Canadian Researchers in Sequencing Covid-19 Virus Genome
December 2020
Adjunct Professor Carl Hansesn’s company AbCellera makes waves with successful IPO
Dr. Martin Hirst’s lab pilots new COVID-19 testing and cleaning protocols
April 2021
Dr. Leonard Foster speaks on how cloud computing support accelerates COVID-19 vaccine improvements
